25 results on '"Cairns AG"'
Search Results
2. Effect of a multicomponent nutritional supplement on functional outcomes for Duchenne muscular dystrophy: A randomized controlled trial
- Author
-
Davidson, ZE, Hughes, I, Ryan, MM, Kornberg, AJ, Cairns, AG, Jones, K, Hutchence, M, Sampaio, H, Morrison, M, Truby, H, Davidson, ZE, Hughes, I, Ryan, MM, Kornberg, AJ, Cairns, AG, Jones, K, Hutchence, M, Sampaio, H, Morrison, M, and Truby, H
- Abstract
BACKGROUND & AIMS: Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular condition causing progressive muscle weakness and premature death. Whilst effective treatments such as gene therapy are developed, families often seek complementary therapies such as nutrition supplements to help their son maintain function; however, there is limited evidence supporting the use of nutritional supplements in DMD. This study aimed to compare the effect of a Standard nutritional supplement with an Enhanced nutritional supplement combining three nutriceuticals on functional outcomes in ambulatory boys with Duchenne muscular dystrophy (DMD). DESIGN: A 50-week double blinded, randomized, controlled crossover trial was conducted in four Australian neuromuscular centres. Primary outcome measures were 6-min walk distance (6MWD) and community ambulation (StepWatch™ Activity Monitoring). Secondary outcome measures included body composition and quality of life. Serum 25-hydroxyvitamin D was measured. RESULTS: Twenty-seven boys completed the intervention. Traditional crossover analysis demonstrated the Enhanced supplement compared to the Standard supplement was associated with a difference of +12 (95% CI: -16, 40) metres in 6MWD, +0.5 (95% CI: -53, 54) inactive minutes per day and -95 (95% CI: -887, 696) steps per day. A mixed effect model indicated a potentially clinically important effect of the Enhanced supplement on the 6MWD of +31 (95% CI: -19, 81) metres. Mean serum 25 hydroxyvitamin D levels at week 50 was 94 (95% CI: 84, 104) nmol/L. There was no observable effect of either supplement regime on body composition or quality of life. CONCLUSIONS: Whilst a positive effect of the Enhanced supplement on functional outcomes was observed, this finding was inconclusive due to the small sample size. The results do not support the use of combined nutritional supplements to improve body composition or quality of life in DMD. A dose of 2000 IU vitamin D was an adequate dose to raise ser
- Published
- 2021
3. Intra-striatal infusion of the small molecule alpha-synuclein aggregator, FN075, does not enhance parkinsonism in a subclinical AAV-alpha-synuclein rat model.
- Author
-
Patton T, Comini G, Narasimhan K, Cairns AG, Ådén J, Almqvist F, Bemelmans A, Brouillet E, McKernan DP, and Dowd E
- Abstract
Numerous challenges hinder the development of neuroprotective treatments for Parkinson's disease, with a regularly identified issue being the lack of clinically relevant animal models. Viral vector overexpression of α-synuclein is widely considered the most relevant model; however, this has been limited by high variability and inconsistency. One potential method of optimisation is pairing it with a secondary insult such as FN075, a synthetic molecule demonstrated to accelerate α-synucleinopathy. Thus, the aim of this study was to investigate if sequential infusion of adeno-associated virus (AAV)-α-synuclein and FN075 into the rat brain can replicate α-synucleinopathy, nigrostriatal pathology and motor dysfunction associated with Parkinson's disease. Rats received a unilateral injection of AAV-α-synuclein (or AAV-green fluorescent protein) into two sites in the substantia nigra, followed 4 weeks later by unilateral injection of FN075 (or vehicle) into the striatum. Animals underwent behavioural testing every 4 weeks until sacrifice at 20 weeks, followed by immunohistochemistry assessment post-mortem. As anticipated, AAV-α-synuclein led to extensive overexpression of human α-synuclein throughout the nigrostriatal pathway, as well as elevated levels of phosphorylated and aggregated forms of the protein. However, the sequential administration of FN075 into the striatum did not exacerbate any of the α-synuclein pathology. Furthermore, despite the extensive α-synuclein pathology, neither administration of AAV-α-synuclein nor FN075, alone or in combination, was sufficient to induce dopaminergic degeneration or motor deficits. In conclusion, this approach did not replicate the key characteristics of Parkinson's disease, and further studies are required to create more representational models for testing of novel compounds and treatments for Parkinson's disease., (© 2024 The Author(s). European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
4. Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?
- Author
-
Kuemper S, Cairns AG, Birchall K, Yao Z, and Large JM
- Abstract
Targeted protein degradation (TPD) is a rapidly expanding field, with various PROTACs (proteolysis-targeting chimeras) in clinical trials and molecular glues such as immunomodulatory imide drugs (IMiDs) already well established in the treatment of certain blood cancers. Many current approaches are focused on oncology targets, leaving numerous potential applications underexplored. Targeting proteins for degradation offers a novel therapeutic route for targets whose inhibition remains challenging, such as protein aggregates in neurodegenerative diseases. This mini review focuses on the prospect of utilizing TPD for neurodegenerative disease targets, particularly PROTAC and molecular glue formats and opportunities for novel CNS E3 ligases. Some key challenges of utilizing such modalities including molecular design of degrader molecules, drug delivery and blood brain barrier penetrance will be discussed., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Kuemper, Cairns, Birchall, Yao and Large.)
- Published
- 2024
- Full Text
- View/download PDF
5. The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models.
- Author
-
Kelly R, Cairns AG, Ådén J, Almqvist F, Bemelmans AP, Brouillet E, Patton T, McKernan DP, and Dowd E
- Subjects
- Animals, Rats, Humans, Parkinson Disease metabolism, Parkinson Disease pathology, Parkinson Disease genetics, Male, Genetic Vectors, Rats, Sprague-Dawley, Corpus Striatum metabolism, Corpus Striatum pathology, alpha-Synuclein metabolism, alpha-Synuclein genetics, Dependovirus genetics, Disease Models, Animal, Substantia Nigra metabolism, Substantia Nigra pathology
- Abstract
Animal models of Parkinson's disease, in which the human α-synuclein transgene is overexpressed in the nigrostriatal pathway using viral vectors, are widely considered to be the most relevant models of the human condition. However, although highly valid, these models have major limitations related to reliability and variability, with many animals exhibiting pronounced α-synuclein expression failing to demonstrate nigrostriatal neurodegeneration or motor dysfunction. Therefore, the aim of this study was to determine if sequential intra-nigral administration of AAV-α-synuclein followed by the small α-synuclein aggregating molecule, FN075, would enhance or precipitate the associated α-synucleinopathy, nigrostriatal pathology and motor dysfunction in subclinical models. Rats were given unilateral intra-nigral injections of AAV-α-synuclein (either wild-type or A53T mutant) followed four weeks later by a unilateral intra-nigral injection of FN075, after which they underwent behavioral testing for lateralized motor functionality until they were sacrificed for immunohistological assessment at 20 weeks after AAV administration. In line with expectations, both of the AAV vectors induced widespread overexpression of human α-synuclein in the substantia nigra and striatum. Sequential administration of FN075 significantly enhanced the α-synuclein pathology with increased density and accumulation of the pathological form of the protein phosphorylated at serine 129 (pS129-α-synuclein). However, despite this enhanced α-synuclein pathology, FN075 did not precipitate nigrostriatal degeneration or motor dysfunction in these subclinical AAV models. In conclusion, FN075 holds significant promise as an approach to enhancing the α-synuclein pathology in viral overexpression models, but further studies are required to determine if alternative administration regimes for this molecule could improve the reliability and variability in these models.
- Published
- 2021
- Full Text
- View/download PDF
6. Effect of a multicomponent nutritional supplement on functional outcomes for Duchenne muscular dystrophy: A randomized controlled trial.
- Author
-
Davidson ZE, Hughes I, Ryan MM, Kornberg AJ, Cairns AG, Jones K, Hutchence M, Sampaio H, Morrison M, and Truby H
- Subjects
- Australia, Body Composition, Cross-Over Studies, Double-Blind Method, Functional Status, Humans, Male, Minimal Clinically Important Difference, Quality of Life, Vitamin D analogs & derivatives, Vitamin D blood, Walk Test, Dietary Supplements, Muscular Dystrophy, Duchenne physiopathology, Muscular Dystrophy, Duchenne therapy, Nutritional Physiological Phenomena, Walking physiology
- Abstract
Background & Aims: Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular condition causing progressive muscle weakness and premature death. Whilst effective treatments such as gene therapy are developed, families often seek complementary therapies such as nutrition supplements to help their son maintain function; however, there is limited evidence supporting the use of nutritional supplements in DMD. This study aimed to compare the effect of a Standard nutritional supplement with an Enhanced nutritional supplement combining three nutriceuticals on functional outcomes in ambulatory boys with Duchenne muscular dystrophy (DMD)., Design: A 50-week double blinded, randomized, controlled crossover trial was conducted in four Australian neuromuscular centres. Primary outcome measures were 6-min walk distance (6MWD) and community ambulation (StepWatch™ Activity Monitoring). Secondary outcome measures included body composition and quality of life. Serum 25-hydroxyvitamin D was measured., Results: Twenty-seven boys completed the intervention. Traditional crossover analysis demonstrated the Enhanced supplement compared to the Standard supplement was associated with a difference of +12 (95% CI: -16, 40) metres in 6MWD, +0.5 (95% CI: -53, 54) inactive minutes per day and -95 (95% CI: -887, 696) steps per day. A mixed effect model indicated a potentially clinically important effect of the Enhanced supplement on the 6MWD of +31 (95% CI: -19, 81) metres. Mean serum 25 hydroxyvitamin D levels at week 50 was 94 (95% CI: 84, 104) nmol/L. There was no observable effect of either supplement regime on body composition or quality of life., Conclusions: Whilst a positive effect of the Enhanced supplement on functional outcomes was observed, this finding was inconclusive due to the small sample size. The results do not support the use of combined nutritional supplements to improve body composition or quality of life in DMD. A dose of 2000 IU vitamin D was an adequate dose to raise serum 25-hydroxyvitamin D over 50 weeks., Clinical Trial Registry: Registry #: ACTRN12610000462088, http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12610000462088., Competing Interests: Conflicts of interest The authors have no conflicts of interests to declare., (Copyright © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
7. Insights on Targeting Small Molecules to the Mitochondrial Matrix and the Preparation of MitoB and MitoP as Exomarkers of Mitochondrial Hydrogen Peroxide.
- Author
-
Cairns AG, McQuaker SJ, Murphy MP, and Hartley RC
- Subjects
- Animals, Humans, Mass Spectrometry, Molecular Structure, Organophosphorus Compounds analysis, Organophosphorus Compounds chemistry, Organophosphorus Compounds pharmacology, Oxidative Stress, Phenols analysis, Phenols chemical synthesis, Phenols chemistry, Phenols pharmacology, Prodrugs chemical synthesis, Prodrugs chemistry, Prodrugs pharmacology, Hydrogen Peroxide analysis, Mitochondria metabolism, Organophosphorus Compounds chemical synthesis
- Abstract
Small molecules can be physicochemically targeted to the mitochondrial matrix using the lipophilic alkyltriphenylphosphonium (TPP) group. Once in the mitochondria the TPP conjugate can detect or influence processes within the mitochondrial matrix directly. Alternatively, the conjugate can behave as a prodrug, which is activated by release from the TPP group either using an internal or external instruction. Small molecules can be designed that can be used in any cell line, tissue, or whole organism, allow for temporal control, and can be applied in a reversible dose-dependent fashion. An example is the detection and quantification of hydrogen peroxide in mitochondria of whole living organisms by MitoB. Hydrogen peroxide produced within the mitochondrial matrix is involved in signaling and implicated in the oxidative damage associated with aging and a wide range of conditions including cardiovascular disease, neurodegeneration, and cancer. MitoB accumulates in mitochondria and is converted into the exomarker, MitoP, by hydrogen peroxide in the mitochondrial matrix. The hydrogen peroxide concentration is determined from the ratio of MitoP to MitoB after a period of incubation, and this ratio is determined by mass spectrometry using d15-MitoP and d15-MitoB as internal standards. Here we discuss the targeting of small molecules to the mitochondrial matrix using TPP, and describe the synthesis of MitoB and MitoP and the deuterated standards necessary for quantification of hydrogen peroxide in the mitochondrial matrix of whole living organisms.
- Published
- 2021
- Full Text
- View/download PDF
8. Methyl sulfonamide substituents improve the pharmacokinetic properties of bicyclic 2-pyridone based Chlamydia trachomatis inhibitors.
- Author
-
Kulén M, Núñez-Otero C, Cairns AG, Silver J, Lindgren AEG, Wede E, Singh P, Vielfort K, Bahnan W, Good JAD, Svensson R, Bergström S, Gylfe Å, and Almqvist F
- Abstract
Chlamydia trachomatis infections are a global health problem and new approaches to treat C. trachomatis with drugs of high specificity would be valuable. A library of substituted ring fused 2-pyridones has been synthesized and evaluated for their ability to attenuate C. trachomatis infectivity. In vivo pharmacokinetic studies were performed, with the best candidates demonstrating that a C8-methylsulfonamide substituent improved pharmacokinetic properties important for oral administration. C8-Methyl sulfonamide analogue 30 inhibited C. trachomatis infectivity in low micromolar concentrations. Further pharmacokinetic evaluation at an oral dose of 10 mg kg
-1 showed an apparent bioavailability of 41%, compared to C8-cyclopropyl and -methoxy analogues which had negligible oral uptake. In vitro ADME (absorption, distribution, metabolism and excretion) testing of solubility and Caco-2 cell permeability revealed that both solubility and permeability is greatly improved with the C8-methyl sulfonamide 30 , effectively moving it from BCS (Biopharmaceutical Classification System) class IV to II., (This journal is © The Royal Society of Chemistry 2019.)- Published
- 2019
- Full Text
- View/download PDF
9. Synthesis of Densely Functionalized N -Alkenyl 2-Pyridones via Benzyne-Induced Ring Opening of Thiazolino-Fused 2-Pyridones.
- Author
-
Singh P, Cairns AG, Adolfsson DE, Ådén J, Sauer UH, and Almqvist F
- Subjects
- Cycloaddition Reaction, Molecular Structure, Pyridones chemistry, Benzene Derivatives chemistry, Pyridones chemical synthesis, Thiazoles chemistry
- Abstract
We report the synthesis of 6-arylthio-substituted- N -alkenyl 2-pyridones by ring opening of bicyclic thiazolino-2-pyridones with arynes. Varied functionalization was used to investigate scope and substituent influences on reactivity. Selected conditions favor thioether ring opening over [4 + 2] cycloaddition and an unusual aryne incorporating ring expansion. Deuterium labeling was used to clarify observed reactivity. Using the knowledge, we produced drug-like molecules with complex substitution patterns and show how thioether ring opening can be used on scaffolds with competing reactivities.
- Published
- 2019
- Full Text
- View/download PDF
10. Viral mimetic priming enhances α-synuclein-induced degeneration: Implications for Parkinson's disease.
- Author
-
Olsen LK, Cairns AG, Ådén J, Moriarty N, Cabre S, Alamilla VR, Almqvist F, Dowd E, and McKernan DP
- Subjects
- Animals, Biomimetic Materials, Corpus Striatum metabolism, Dependovirus genetics, Disease Models, Animal, Genetic Vectors, Gliosis metabolism, Male, Motor Activity drug effects, Neurodegenerative Diseases etiology, Neurodegenerative Diseases physiopathology, Neuroimmunomodulation physiology, Neurons metabolism, Parkinson Disease metabolism, Parkinson Disease physiopathology, Poly I-C administration & dosage, Protein Aggregation, Pathological metabolism, Protein Aggregation, Pathological virology, Rats, Rats, Sprague-Dawley, Substantia Nigra metabolism, Tyrosine 3-Monooxygenase metabolism, alpha-Synuclein physiology, Parkinson Disease etiology, Poly I-C adverse effects, alpha-Synuclein metabolism
- Abstract
Evidence is accumulating to suggest that viral infections and consequent viral-mediated neuroinflammation may contribute to the etiology of idiopathic Parkinson's disease. Moreover, viruses have been shown to influence α-synuclein oligomerization as well as the autophagic clearance of abnormal intra-cellular proteins aggregations, both of which are key neuropathological events in Parkinson's disease pathogenesis. To further investigate the interaction between viral-mediated neuroinflammation and α-synuclein aggregation in the context of Parkinson's disease, this study sought to determine the impact of viral neuroinflammatory priming on α-synuclein aggregate-induced neuroinflammation and neurotoxicity in the rat nigrostriatal pathway. To do so, male Sprague-Dawley rats were intra-nigrally injected with a synthetic mimetic of viral dsRNA (poly I:C) followed two weeks later by a peptidomimetic small molecule which accelerates α-synuclein fibril formation (FN075). The impact of the viral priming on α-synuclein aggregation-induced neuroinflammation, neurodegeneration and motor dysfunction was assessed. We found that prior administration of the viral mimetic poly I:C significantly exacerbated or precipitated the α-synuclein aggregate induced neuropathological and behavioral effects. Specifically, sequential exposure to the two challenges caused a significant increase in nigral microgliosis (p < 0.001) and astrocytosis (p < 0.01); precipitated a significant degeneration of the nigrostriatal cell bodies (p < 0.05); and precipitated a significant impairment in forelimb kinesis (p < 0.01) and sensorimotor integration (p < 0.01). The enhanced sensitivity of the nigrostriatal neurons to pathological α-synuclein aggregation after viral neuroinflammatory priming further suggests that viral infections may contribute to the etiology and pathogenesis of Parkinson's disease., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
11. Translation of Diverse Aramid- and 1,3-Dicarbonyl-peptides by Wild Type Ribosomes in Vitro .
- Author
-
Ad O, Hoffman KS, Cairns AG, Featherston AL, Miller SJ, Söll D, and Schepartz A
- Abstract
Here, we report that wild type Escherichia coli ribosomes accept and elongate precharged initiator tRNAs acylated with multiple benzoic acids, including aramid precursors, as well as malonyl (1,3-dicarbonyl) substrates to generate a diverse set of aramid-peptide and polyketide-peptide hybrid molecules. This work expands the scope of ribozyme- and ribosome-catalyzed chemical transformations, provides a starting point for in vivo translation engineering efforts, and offers an alternative strategy for the biosynthesis of polyketide-peptide natural products., Competing Interests: The authors declare no competing financial interest.
- Published
- 2019
- Full Text
- View/download PDF
12. Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis .
- Author
-
Flentie K, Harrison GA, Tükenmez H, Livny J, Good JAD, Sarkar S, Zhu DX, Kinsella RL, Weiss LA, Solomon SD, Schene ME, Hansen MR, Cairns AG, Kulén M, Wixe T, Lindgren AEG, Chorell E, Bengtsson C, Krishnan KS, Hultgren SJ, Larsson C, Almqvist F, and Stallings CL
- Subjects
- Drug Evaluation, Preclinical, Antitubercular Agents pharmacology, Drug Resistance, Bacterial drug effects, Isoniazid, Mycobacterium tuberculosis drug effects
- Abstract
Mycobacterium tuberculosis ( Mtb ) killed more people in 2017 than any other single infectious agent. This dangerous pathogen is able to withstand stresses imposed by the immune system and tolerate exposure to antibiotics, resulting in persistent infection. The global tuberculosis (TB) epidemic has been exacerbated by the emergence of mutant strains of Mtb that are resistant to frontline antibiotics. Thus, both phenotypic drug tolerance and genetic drug resistance are major obstacles to successful TB therapy. Using a chemical approach to identify compounds that block stress and drug tolerance, as opposed to traditional screens for compounds that kill Mtb , we identified a small molecule, C10, that blocks tolerance to oxidative stress, acid stress, and the frontline antibiotic isoniazid (INH). In addition, we found that C10 prevents the selection for INH-resistant mutants and restores INH sensitivity in otherwise INH-resistant Mtb strains harboring mutations in the katG gene, which encodes the enzyme that converts the prodrug INH to its active form. Through mechanistic studies, we discovered that C10 inhibits Mtb respiration, revealing a link between respiration homeostasis and INH sensitivity. Therefore, by using C10 to dissect Mtb persistence, we discovered that INH resistance is not absolute and can be reversed., Competing Interests: Conflict of interest statement: C.L.S., S.J.H., and F.A. have ownership interests in Quretech Bio AB, which licenses C10.
- Published
- 2019
- Full Text
- View/download PDF
13. Pyridine-Fused 2-Pyridones via Povarov and A 3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril Binding.
- Author
-
Singh P, Adolfsson DE, Ådén J, Cairns AG, Bartens C, Brännström K, Olofsson A, and Almqvist F
- Subjects
- Bridged Bicyclo Compounds, Heterocyclic, Heterocyclic Compounds, Bridged-Ring chemistry, Pyridines chemistry, Pyridones chemistry, Structure-Activity Relationship, Styrenes chemistry, Amyloid chemistry, Heterocyclic Compounds, Bridged-Ring chemical synthesis, Pyridines chemical synthesis, Pyridones chemical synthesis
- Abstract
We here describe the use of three-component reactions to synthesize tricyclic pyridine ring-fused 2-pyridones. The developed protocols have a wide substrate scope and allow for the installation of diverse chemical functionalities on the tricyclic central fragment. Several of these pyridine-fused rigid polyheterocycles are shown to bind to Aβ and α-synuclein fibrils, which are associated with neurodegenerative diseases.
- Published
- 2019
- Full Text
- View/download PDF
14. Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy.
- Author
-
Cairns AG, Vazquez-Romero A, Mahdi Moein M, Ådén J, Elmore CS, Takano A, Arakawa R, Varrone A, Almqvist F, and Schou M
- Subjects
- Animals, Brain diagnostic imaging, Carbon Radioisotopes, Esters chemistry, Macaca mulatta, Peptidomimetics chemistry, Positron-Emission Tomography, Pyridones chemistry, Thiazoles chemistry, alpha-Synuclein metabolism, Blood-Brain Barrier metabolism, Brain metabolism, Esters pharmacology, Peptidomimetics pharmacology, Prodrugs pharmacology, Pyridones pharmacology, Thiazoles pharmacology, alpha-Synuclein drug effects
- Abstract
Previous work in our laboratories has identified a series of peptidomimetic 2-pyridone molecules as modulators of alpha-synuclein (α-syn) fibrillization in vitro. As a first step toward developing molecules from this scaffold as positron emission tomography imaging agents, we were interested in evaluating their blood-brain barrier permeability in nonhuman primates (NHP) in vivo. For this purpose, 2-pyridone 12 was prepared and found to accelerate α-syn fibrillization in vitro. Acid 12, and its acetoxymethyl ester analogue 14, were then radiolabeled with
11 C ( t1/2 = 20.4 min) at high radiochemical purity (>99%) and high specific radioactivity (>37 GBq/μmol). Following intravenous injection of each compound in NHP, a 4-fold higher radioactivity in brain was observed for [11 C]14 compared to [11 C]12 (0.8 vs 0.2 SUV, respectively). [11 C]14 was rapidly eliminated from plasma, with [11 C]12 as the major metabolic product observed by radio-HPLC. The presented prodrug approach paves the way for future development of 2-pyridones as imaging biomarkers for in vivo imaging of α-synuclein deposits in brain.- Published
- 2018
- Full Text
- View/download PDF
15. Structure-Based Design of Inhibitors Targeting PrfA, the Master Virulence Regulator of Listeria monocytogenes.
- Author
-
Kulén M, Lindgren M, Hansen S, Cairns AG, Grundström C, Begum A, van der Lingen I, Brännström K, Hall M, Sauer UH, Johansson J, Sauer-Eriksson AE, and Almqvist F
- Subjects
- Animals, Bacterial Proteins chemistry, Bacterial Proteins metabolism, Chick Embryo, Listeria monocytogenes pathogenicity, Models, Molecular, Peptide Termination Factors chemistry, Peptide Termination Factors metabolism, Protein Conformation, Virulence drug effects, Anti-Bacterial Agents chemistry, Anti-Bacterial Agents pharmacology, Bacterial Proteins antagonists & inhibitors, Drug Design, Listeria monocytogenes drug effects, Listeria monocytogenes metabolism, Peptide Termination Factors antagonists & inhibitors
- Abstract
Listeria monocytogenes is a bacterial pathogen that controls much of its virulence through the transcriptional regulator PrfA. In this study, we describe structure-guided design and synthesis of a set of PrfA inhibitors based on ring-fused 2-pyridone heterocycles. Our most effective compound decreased virulence factor expression, reduced bacterial uptake into eukaryotic cells, and improved survival of chicken embryos infected with L. monocytogenes compared to previously identified compounds. Crystal structures identified an intraprotein "tunnel" as the main inhibitor binding site (A
I ), where the compounds participate in an extensive hydrophobic network that restricts the protein's ability to form functional DNA-binding helix-turn-helix (HTH) motifs. Our studies also revealed a hitherto unsuspected structural plasticity of the HTH motif. In conclusion, we have designed 2-pyridone analogues that function as site-AI selective PrfA inhibitors with potent antivirulence properties.- Published
- 2018
- Full Text
- View/download PDF
16. MitoNeoD: A Mitochondria-Targeted Superoxide Probe.
- Author
-
Shchepinova MM, Cairns AG, Prime TA, Logan A, James AM, Hall AR, Vidoni S, Arndt S, Caldwell ST, Prag HA, Pell VR, Krieg T, Mulvey JF, Yadav P, Cobley JN, Bright TP, Senn HM, Anderson RF, Murphy MP, and Hartley RC
- Subjects
- Animals, Biological Transport, Cell Line, DNA chemistry, DNA metabolism, Male, Mass Spectrometry, Mice, Models, Molecular, Molecular Probes chemistry, Nucleic Acid Conformation, Oxidation-Reduction, Mitochondria metabolism, Molecular Probes metabolism, Superoxides metabolism
- Abstract
Mitochondrial superoxide (O
2 ⋅- ) underlies much oxidative damage and redox signaling. Fluorescent probes can detect O2 ⋅- , but are of limited applicability in vivo, while in cells their usefulness is constrained by side reactions and DNA intercalation. To overcome these limitations, we developed a dual-purpose mitochondrial O2 ⋅- probe, MitoNeoD, which can assess O2 ⋅- changes in vivo by mass spectrometry and in vitro by fluorescence. MitoNeoD comprises a O2 ⋅- -sensitive reduced phenanthridinium moiety modified to prevent DNA intercalation, as well as a carbon-deuterium bond to enhance its selectivity for O2 ⋅- over non-specific oxidation, and a triphenylphosphonium lipophilic cation moiety leading to the rapid accumulation within mitochondria. We demonstrated that MitoNeoD was a versatile and robust probe to assess changes in mitochondrial O2 ⋅- from isolated mitochondria to animal models, thus offering a way to examine the many roles of mitochondrial O2 ⋅- production in health and disease., (Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
17. Using the MitoB method to assess levels of reactive oxygen species in ecological studies of oxidative stress.
- Author
-
Salin K, Auer SK, Villasevil EM, Anderson GJ, Cairns AG, Mullen W, Hartley RC, and Metcalfe NB
- Subjects
- Animals, Mitochondria drug effects, Phenols administration & dosage, Trout, Ecology methods, Hydrogen Peroxide analysis, Mitochondria metabolism, Organophosphorus Compounds administration & dosage, Oxidative Stress, Reactive Oxygen Species analysis
- Abstract
In recent years evolutionary ecologists have become increasingly interested in the effects of reactive oxygen species (ROS) on the life-histories of animals. ROS levels have mostly been inferred indirectly due to the limitations of estimating ROS from in vitro methods. However, measuring ROS (hydrogen peroxide, H
2 O2 ) content in vivo is now possible using the MitoB probe. Here, we extend and refine the MitoB method to make it suitable for ecological studies of oxidative stress using the brown trout Salmo trutta as model. The MitoB method allows an evaluation of H2 O2 levels in living organisms over a timescale from hours to days. The method is flexible with regard to the duration of exposure and initial concentration of the MitoB probe, and there is no transfer of the MitoB probe between fish. H2 O2 levels were consistent across subsamples of the same liver but differed between muscle subsamples and between tissues of the same animal. The MitoB method provides a convenient method for measuring ROS levels in living animals over a significant period of time. Given its wide range of possible applications, it opens the opportunity to study the role of ROS in mediating life history trade-offs in ecological settings.- Published
- 2017
- Full Text
- View/download PDF
18. Regio- and Stereoselective Alkylation of Pyridine-N-oxides: Synthesis of Substituted Piperidines and Pyridines.
- Author
-
Barange DK, Johnson MT, Cairns AG, Olsson R, and Almqvist F
- Abstract
Regio- and stereoselective addition of alkyl Grignard reagents to pyridine-N-oxides gave C2-alkylated N-hydroxy-1,2,5,6-tetrahydropyridines and trans-2,3-disubstituted N-hydroxy-1,2,5,6-tetrahydropyridines in good to excellent yields. These intermediates were aromatized or alternatively reduced in one-pot methodologies for efficient syntheses of alkylpyridines or piperidines, respectively. These reactions have a broad substrate scope and short reaction times.
- Published
- 2016
- Full Text
- View/download PDF
19. Synthesis of an azido-tagged low affinity ratiometric calcium sensor.
- Author
-
Caldwell ST, Cairns AG, Olson M, Chalmers S, Sandison M, Mullen W, McCarron JG, and Hartley RC
- Abstract
Changes in high localised concentrations of Ca
2+ ions are fundamental to cell signalling. The synthesis of a dual excitation, ratiometric calcium ion sensor with a Kd of 90 μM, is described. It is tagged with an azido group for bioconjugation, and absorbs in the blue/green and emits in the red region of the visible spectrum with a large Stokes shift. The binding modulating nitro group is introduced to the BAPTA core prior to construction of a benzofuran-2-yl carboxaldehyde by an allylation-oxidation-cyclisation sequence, which is followed by condensation with an azido-tagged thiohydantoin. The thiohydantoin unit has to be protected with an acetoxymethyl (AM) caging group to allow CuAAC click reaction and incorporation of the KDEL peptide endoplasmic reticulum (ER) retention sequence.- Published
- 2015
- Full Text
- View/download PDF
20. Individuals with higher metabolic rates have lower levels of reactive oxygen species in vivo.
- Author
-
Salin K, Auer SK, Rudolf AM, Anderson GJ, Cairns AG, Mullen W, Hartley RC, Selman C, and Metcalfe NB
- Subjects
- Animals, Hydrogen Peroxide metabolism, Mitochondria metabolism, Oxidative Stress, Basal Metabolism physiology, Oxygen Consumption, Reactive Oxygen Species metabolism, Trout metabolism
- Abstract
There is increasing interest in the effect of energy metabolism on oxidative stress, but much ambiguity over the relationship between the rate of oxygen consumption and the generation of reactive oxygen species (ROS). Production of ROS (such as hydrogen peroxide, H2O2) in the mitochondria is primarily inferred indirectly from measurements in vitro, which may not reflect actual ROS production in living animals. Here, we measured in vivo H2O2 content using the recently developed MitoB probe that becomes concentrated in the mitochondria of living organisms, where it is converted by H2O2 into an alternative form termed MitoP; the ratio of MitoP/MitoB indicates the level of mitochondrial H2O2 in vivo. Using the brown trout Salmo trutta, we tested whether this measurement of in vivo H2O2 content over a 24 h-period was related to interindividual variation in standard metabolic rate (SMR). We showed that the H2O2 content varied up to 26-fold among fish of the same age and under identical environmental conditions and nutritional states. Interindividual variation in H2O2 content was unrelated to mitochondrial density but was significantly associated with SMR: fish with a higher mass-independent SMR had a lower level of H2O2. The mechanism underlying this observed relationship between SMR and in vivo H2O2 content requires further investigation, but may implicate mitochondrial uncoupling which can simultaneously increase SMR but reduce ROS production. To our knowledge, this is the first study in living organisms to show that individuals with higher oxygen consumption rates can actually have lower levels of H2O2., (© 2015 The Authors.)
- Published
- 2015
- Full Text
- View/download PDF
21. Targeting mitochondria with small molecules: the preparation of MitoB and MitoP as exomarkers of mitochondrial hydrogen peroxide.
- Author
-
Cairns AG, McQuaker SJ, Murphy MP, and Hartley RC
- Subjects
- Hydrogen Peroxide metabolism, Organophosphorus Compounds chemical synthesis, Organophosphorus Compounds isolation & purification, Organophosphorus Compounds metabolism, Organophosphorus Compounds pharmacology, Oxidation-Reduction drug effects, Phenols chemical synthesis, Phenols isolation & purification, Phenols metabolism, Phenols pharmacology, Reactive Oxygen Species metabolism, Drug Discovery methods, Mitochondria drug effects, Mitochondria metabolism
- Abstract
Small molecules can be physicochemically targeted to mitochondria using the lipophilic alkyltriphenylphosphonium (TPP) group. Once in the mitochondria the TPP-conjugate can detect or influence processes within the mitochondrial matrix directly. Alternatively, the conjugate can behave as a prodrug, which is activated by release from the TPP group either using an internal or external instruction. Small molecules can be designed that can be used in any cell line, tissue or whole organism, allow temporal control, and be applied in a reversible dose-dependent fashion. An example is the detection and quantification of hydrogen peroxide in mitochondria of whole living organisms by MitoB. Hydrogen peroxide produced within the mitochondrial matrix is involved in signalling and implicated in the oxidative damage associated with aging and a wide range of age-associated conditions including cardiovascular disease, neurodegeneration, and cancer. MitoB accumulates in mitochondria and is converted into the exomarker, MitoP, by hydrogen peroxide in the mitochondrial matrix. The hydrogen peroxide concentration is determined from the ratio of MitoP to MitoB after a period of incubation, and this ratio is determined by mass spectrometry using d15-MitoP and d15-MitoB as standard. Here we describe the synthesis of MitoB and MitoP and the deuterated standards necessary for this method of quantification.
- Published
- 2015
- Full Text
- View/download PDF
22. Expanding the palette of phenanthridinium cations.
- Author
-
Cairns AG, Senn HM, Murphy MP, and Hartley RC
- Subjects
- Cations, Computer Simulation, Cyclization, Fluorescent Dyes chemical synthesis, Intercalating Agents, Models, Chemical, Molecular Structure, Phenanthridines chemical synthesis, DNA chemistry, Fluorescent Dyes chemistry, Phenanthridines chemistry
- Abstract
5,6-Disubstituted phenanthridinium cations have a range of redox, fluorescence and biological properties. Some properties rely on phenanthridiniums intercalating into DNA, but the use of these cations as exomarkers for the reactive oxygen species (ROS), superoxide, and as inhibitors of acetylcholine esterase (AChE) do not require intercalation. A versatile modular synthesis of 5,6-disubstituted phenanthridiniums that introduces diversity by Suzuki–Miyaura coupling, imine formation and microwave-assisted cyclisation is presented. Computational modelling at the density functional theory (DFT) level reveals that the novel displacement of the aryl halide by an acyclic N-alkylimine proceeds by an S(N)Ar mechanism rather than electrocyclisation. It is found that the displacement of halide is concerted and there is no stable Meisenheimer intermediate, provided the calculations consistently use a polarisable solvent model and a diffuse basis set.
- Published
- 2014
- Full Text
- View/download PDF
23. Selective uncoupling of individual mitochondria within a cell using a mitochondria-targeted photoactivated protonophore.
- Author
-
Chalmers S, Caldwell ST, Quin C, Prime TA, James AM, Cairns AG, Murphy MP, McCarron JG, and Hartley RC
- Subjects
- Animals, Cells, Cultured, Drug Delivery Systems, Molecular Structure, Myocytes, Smooth Muscle drug effects, Myocytes, Smooth Muscle physiology, Organometallic Compounds pharmacology, Ultraviolet Rays, Mitochondria physiology, Organophosphorus Compounds chemistry
- Abstract
Depolarization of an individual mitochondrion or small clusters of mitochondria within cells has been achieved using a photoactivatable probe. The probe is targeted to the matrix of the mitochondrion by an alkyltriphenylphosphonium lipophilic cation and releases the protonophore 2,4-dinitrophenol locally in predetermined regions in response to directed irradiation with UV light via a local photolysis system. This also provides a proof of principle for the general temporally and spatially controlled release of bioactive molecules, pharmacophores, or toxins to mitochondria with tissue, cell, or mitochondrion specificity., (© 2011 American Chemical Society)
- Published
- 2012
- Full Text
- View/download PDF
24. Cerebrovascular dysplasia in neurofibromatosis type 1.
- Author
-
Cairns AG and North KN
- Subjects
- Brain Neoplasms congenital, Child, Female, Humans, Magnetic Resonance Angiography, Magnetic Resonance Imaging, Male, Mass Screening, Prospective Studies, Brain Neoplasms diagnosis, Brain Neoplasms epidemiology, Neurofibromatosis 1 diagnosis, Neurofibromatosis 1 epidemiology
- Abstract
Objective: To assess the frequency and clinical characteristics of the increasingly recognised complication of cerebrovascular dysplasia in children with neurofibromatosis type 1 (NF1)., Methods: A series of seven patients with NF1 and cerebrovascular dysplasias that were not secondary to radiotherapy were identified and prospectively assessed. An extensive review of the literature was also performed to identify associated features and the natural history of this potentially severe complication of NF1., Results: The frequency of cerebrovascular dysplasia in NF1 was found to be 2-5%, and vascular lesions were clearly visible on routine MRI of the brain. The majority of patients were clinically asymptomatic, despite angiographic progression in some cases. Hypoplastic carotid canals and early appearance on MRI suggested that a proportion of cases of cerebrovascular dysplasia were congenital in origin., Conclusion: These findings have implications for screening of asymptomatic patients with NF1, and highlight the difficult management decisions in those patients identified with cerebrovascular malformations.
- Published
- 2008
- Full Text
- View/download PDF
25. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.
- Author
-
Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, Tay V, Compton AG, Cairns AG, Corbett A, MacArthur DG, Yang N, Reardon K, and North KN
- Subjects
- Caveolin 1 genetics, Caveolin 1 metabolism, Cohort Studies, Cytoplasm metabolism, Cytoplasm pathology, DNA Mutational Analysis, Dysferlin, Gene Frequency, Genetic Testing, Humans, Membrane Proteins metabolism, Muscle Fibers, Skeletal metabolism, Muscle Fibers, Skeletal pathology, Muscle Proteins metabolism, Muscle, Skeletal metabolism, Muscular Dystrophies, Limb-Girdle classification, Mutation genetics, Protein Transport genetics, Regeneration genetics, Retrospective Studies, Sarcolemma metabolism, Sarcolemma pathology, Genetic Predisposition to Disease genetics, Membrane Proteins genetics, Muscle Proteins genetics, Muscle, Skeletal pathology, Muscle, Skeletal physiopathology, Muscular Dystrophies, Limb-Girdle diagnosis, Muscular Dystrophies, Limb-Girdle genetics
- Abstract
We characterized the frequency of limb-girdle muscular dystrophy (LGMD) subtypes in a cohort of 76 Australian muscular dystrophy patients using protein and DNA sequence analysis. Calpainopathies (8%) and dysferlinopathies (5%) are the most common causes of LGMD in Australia. In contrast to European populations, cases of LGMD2I (due to mutations in FKRP) are rare in Australasia (3%). We have identified a cohort of patients in whom all common disease candidates have been excluded, providing a valuable resource for identification of new disease genes. Cytoplasmic localization of dysferlin correlates with fiber regeneration in a subset of muscular dystrophy patients. In addition, we have identified a group of patients with unidentified forms of LGMD and with markedly abnormal dysferlin localization that does not correlate with fiber regeneration. This pattern is mimicked in primary caveolinopathy, suggesting a subset of these patients may also possess mutations within proteins required for membrane targeting of dysferlin.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.